Association of polymorphisms in <i>GCKR</i> and <i>TRIB1</i> with nonalcoholic fatty liver disease and metabolic syndrome traits-Reference-Cited by-同舟云学术

Association of polymorphisms in GCKR and TRIB1 with nonalcoholic fatty liver disease and metabolic syndrome traits

Published:2014 Issue:7 Volume:61 Page:683-689
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Kitamoto Aya¹,Kitamoto Takuya¹,Nakamura Takahiro²,Ogawa Yuji³,Yoneda Masato³,Hyogo Hideyuki⁴,Ochi Hidenori⁴,Mizusawa Seiho¹,Ueno Takato⁵,Nakao Kazuwa⁶,Sekine Akihiro¹,Chayama Kazuaki⁴,Nakajima Atsushi³,Hotta Kikuko¹

Affiliation:

1. Medical Research Support Center, Pharmacogenomics, Kyoto University Graduate School of Medicine, Kyoto 606-8501, Japan

2. Laboratory for Mathematics, National Defense Medical College, Tokorozawa 359-8513, Japan

3. Division of Gastroenterology, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan

4. Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima 734-8551, Japan

5. Research Center for Innovative Cancer Therapy, Kurume University, Kurume 830-0011, Japan

6. Medical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto 606-8501, Japan

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/61/7/61_EJ14-0052/_pdf

Reference32 articles.

1. 1. Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346: 1221-1231.

2. 2. Farrell GC (2003) Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region? J Gastroenterol Hepatol 18: 124-138.

3. 3. Okanoue T, Umemura A, Yasui K, Itoh Y (2011) Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Japan. J Gastroenterol Hepatol 26 Suppl 1: 153-162.

4. 4. Ludwig J, Viggiano TR, McGill DB, Oh BJ (1980) Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55: 434-438.

5. 5. Anstee QM, Day CP (2013) The genetics of NAFLD. Nat Rev Gastroenterol Hepatol 10: 645-655.

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MegaMASLD: An interactive platform for exploring stratified transcriptomic signatures in MASLD progression;2024-07-23

2. Abdominal aortic aneurysm and cardiometabolic traits share strong genetic susceptibility to lipid metabolism and inflammation;Nature Communications;2024-07-05

3. Differing genetic variants associated with liver fat and their contrasting relationships with cardiovascular diseases and cancer;Journal of Hepatology;2024-07

4. Associations between metabolic dysfunction-associated fatty liver disease and atherosclerotic cardiovascular disease;The American Journal of the Medical Sciences;2024-06

5. “Oh, Dear We Are in Tribble”: An Overview of the Oncogenic Functions of Tribbles 1;Cancers;2024-05-16